| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2026 | 20 May 2026 |
| Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 inter alia to consider and approve the audited financial results (Standalone and Consolidated) for the quarter and year ended on March 31 2026 and for recommendation of Final Divided for FY 2025-26 on Equity Shares of the Company. Audited Standalone & Consolidated Financial Results for the quarter and year ended on March 31, 2026. (As per BSE announcement dated on :27.05.2026) | ||
| Board Meeting | 13 Feb 2026 | 4 Feb 2026 |
| Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the unaudited consolidated and standalone financial results of the Company for the quarter and nine months ended on December 31 2025. Unaudited Financial Results for the quarter ended on December 31, 2025 (As Per BSE Announcement Dated on:13.02.2026) | ||
| Board Meeting | 14 Nov 2025 | 5 Nov 2025 |
| Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve unaudited Financial Results of the Company for the quarter and half year ended on September 30 2025. Financial Results for the quarter and half year ended on September 30, 2025 (As Per BSE Announcement Dated on: 14/11/2025) | ||
| Board Meeting | 12 Aug 2025 | 7 Aug 2025 |
| Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve unaudited (Standalone and Consolidated) financial results for the quarter ended on June 30 2025. Outcome of the Board meeting held on August 12, 2025 (As Per BSE Announcement Dated on: 12/08/2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
